D-Wave Quantum is sitting on a $590 million cash stockpile and a $42 million order backlog, yet its stock has shed roughly 17% over the past month to trade at €20.89. The jarring disconnect stems from a first-quarter revenue collapse of 81% to just $2.9 million, a figure that reflects a one-off large sale from the prior year rather than any operational setback. New bookings, meanwhile, have surged into double-digit millions, and the company expects about half of its outstanding orders to convert into recognized revenue in the near term.
The market’s anxiety is not about a lack of demand but about timing and consistency. CEO Alan Baratz himself acknowledged the lumpiness of the results. Investors are now waiting to see whether the flood of new contracts can be transformed into steady, recurring income – a test that will be front and center when D-Wave reports second-quarter numbers.
Government Checks Keep the Pipeline Alive
On June 30, D-Wave received a $1.57 million grant from the National Science Foundation for the ERASE project, a joint initiative with Yale University focused on fault‑resistant quantum computing. The company will contribute its hardware platform through its Quantum Circuits LLC subsidiary. The award follows a letter of intent for up to $100 million in funding under the CHIPS Act, underscoring D‑Wave’s alignment with Washington’s strategic push to maintain U.S. leadership in quantum innovation.
While these government infusions bring prestige and operational breathing room, they are dwarfed by the company’s market capitalization of more than $9 billion. Critics argue that such sums, however welcome, are too small to move the needle unless they lead to large commercial contracts.
Analyst Confidence vs. Extreme Volatility
Buy‑side sentiment remains surprisingly bullish. Mizuho recently lifted its price target to $35, citing an expanded technology roadmap. Analyst Vijay Rakesh highlighted plans for a quantum computer with ten logical qubits by the end of the decade and a new developer simulator set to launch in September 2026. The broader addressable market, analysts estimate, could reach hundreds of billions of dollars by 2040.
Should investors sell immediately? Or is it worth buying D-Wave Quantum?
Yet the stock’s behavior tells a different story. Annualized volatility over the past 30 days stands at a staggering 139%, making D‑Wave one of the most unstable names in the quantum sector. The shares have lost nearly 16% in the past four weeks and are trading well below their 52‑week high of €38.48. Over a 12‑month horizon, however, the stock has still gained roughly 68%, a reminder of the spectacular swings that characterize this asset.
The Two Technical Markers That Matter
Given the current price near €21, traders are watching two key moving averages. The 50‑day line at €20.30 offers immediate support; a clean break above that could open the path toward the average analyst target of around €34. The 200‑day moving average, sitting at €20.91, is essentially level with today’s quote, meaning any further weakness could quickly test that floor.
The next catalyst is the expected firming of the CHIPS Act commitment into a binding contract. If D‑Wave converts that letter of intent into a solid award, the stock may find a bottom. Conversely, another disappointing quarterly report – especially one that fails to show progress on converting the backlog – could reignite the sell‑off and threaten the 200‑day line.
Quantum’s High‑Stakes Game
D‑Wave is pursuing a dual‑track strategy: defending its lead in quantum annealing while pushing into fault‑tolerant systems through the ERASE project. That approach has attracted strong federal support, but it also places the company in direct competition with deep‑pocketed rivals like IBM and Quantinuum. The next few quarters will reveal whether the government’s vote of confidence can translate into the kind of commercial momentum that justifies a nine‑billion‑dollar valuation.
Ad
D-Wave Quantum Stock: Buy or Sell?! New D-Wave Quantum Analysis from July 1 delivers the answer:
The latest D-Wave Quantum figures speak for themselves: Urgent action needed for D-Wave Quantum investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 1.
D-Wave Quantum: Buy or sell? Read more here...
